Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis

Kidney International

Volumn 67, Issue 3, 2005, Pages 977-986

  Griffin, Sîan V ^a   Krofft, Ronald D ^a   Pippin, Jeffrey W ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Cyclin dependent kinase; Kidney; Podocyte; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DIMETHYL SULFOXIDE; LAMININ; ROSCOVITINE; CDK2 PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE; DNA; PURINE DERIVATIVE; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; EPITHELIUM CELL; GLOMERULUS; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CDC2-CDC28 KINASES; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; DNA; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; GLOMERULONEPHRITIS; KIDNEY; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; PURINES;

EID: 20844451922     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00161.x     Document Type: Article

References (42)

1. MUNDEL P, SHANKLAND SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13:3005-3015, 2002
2. RENNKE HG: How does glomerular epithelial cell injury contribute to glomerular damage? Kidney Int (Suppl 45):S58-S63, 1994
3. KRIZ W: Progressive renal failure-Inability of podocytes to replicate and the consequences for the development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
4. KRIZ W, GRETZ N, LEMLEY KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 54:687-697, 1998
5. KRIZ W, LEMLEY KV: The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens 8:489-497, 1999
6. KIM YH, GOYAL M, KURNIT D, WHARRAM B, et al: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60:957-968, 2001
7. KRIZ W: Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57:189-195, 2002
8. WHITE KE, BILOUS RW, MARSHALL SM, et al: Podocyte number in normotensive type I diabetic patients with albuminuria. Diabetes 51:3083-3089, 2002
9. LEMLEY KV, LAFAYETTE RA, SAFAI M, et al: Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61:1475-1485, 2002
10. BARISONI L, KRIZ W, MUNDEL P, D'AGATI V: The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental gloermulosclerosis and HIV associated nephropathy. J Am Soc Nephrol 10:51-61, 1999
11. BARISONI L, MOKRZYCKI M, SABLAY L, et al: Podocyte cell cycle regulation and proliferation in collapsing glomerulonephropathies. Kidney Int 58:137-143, 2000
12. DETWILER RK, FALK RJ, HOGAN SL, JENETTE JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994
13. SCHWARTZ MM, EVANS J, BAIN R, KORBET SM: Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion. J Am Soc Nephrol 10:1900-1907, 1999
14. BOUCHER A, DROZ D, ADAFER E, NOEL LH: Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 56:526-533, 1987
15. JENETTE JC, THOMAS DB: Crescentic glomerulonephritis. Nephrol Dial Transplant 16:80-82, 2001
16. LE HIR M, KELLER C, ESCHMANN V, et al: Podocyte bridges between the tuft and Bowman's capsule: An early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 12:2060-2071, 2001
17. OPHASCHAROENSUK V, PIPPIN J, GORDON KL, et al: Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 54:416-425, 1998
18. MOELLER MJ, SOOFI A, HARTMANN I, et al: Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15:61-67, 2004
19. 1 cyclins. Cell 73:1059-1065, 1993
20. MORGAN DO: Principles of CDK regulation. Nature 374:131-134, 1995
21. LEES E: Cyclin dependent kinase regulation. Curr Biol 7:773-780, 1995
22. 1-S phase transition. Mol Cell Biol 15:2612-2623, 1995
23. GIRARD F, STRAUSFIELD U, FERNANDEZ A, LAMB NJ: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179, 1991
24. 1 phase progression. Genes Dev 13:1501-1512, 1999
25. MEIJER L: Chemical inhibitors of cyclin dependent kinases. Trends Cell Biol 10:393-397, 1996
26. SUZUKI J, ISOBE M, MORISHITA R, et al: Prevention of graft coronary arteriosclerosis by antisense CDK2 kinase oligonucleotides. Nat Med 3:900-903, 1997
27. MEIJER L, BORGNE A, MULNER O, et al: Biochemical and cellular effects of Roscovitine, a potent and selective inhibitor of the cyclin dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536, 1997
28. BROOKS EE, GRAY NS, JOLY A, et al: CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem 272:29207-29211, 1997
29. GRAY NS, WODICKA L, THUNNISSEN AM, et al: Exploiting chemical libraries, structure and genomics in the search for kinase inhibitors. Science 281:533-538, 1998
30. GHERADI D, D'AGATI V, TEARINA CHU T-H, et al: Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 15:1212-1222, 2004
31. KIM Y-G, ALPERS CE, BRUGAROLAS J, et al: The cyclin kinase inhibitor p21Cip1/Waf1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 55:2349-2361, 1999
32. COUSER WG, DARBY C, SALANT DJ, et al: Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. Am J Physiol 249:241-250, 1985
33. PIPPIN J, Qu Q, MEIJER L, SHANKLAND SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100:2512-2520, 1997
34. FLOEGE J, JOHNSON RJ, GORDON KL, et al: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-188, 1991
35. BAKER AJ, MOONEY A, LOMBARDI D, et al: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
36. LE HIR M: Histopathology of humorally mediated anti-glomerular basement (GBM) glomerulonephritis in mice. Nephrol Dial Transplant 19:1875-1880, 2004
37. YANG DH, GOYAL M, SHARIF K, et al: Glomerular epithelial protein 1 and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man. Lab Invest 74:571-584, 1996
38. TETSU O, McCORMICK F: Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3:233-245, 2003
39. ORTEGA S, PRIETO I, ODAJIMA J, et al: Cyclin dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 35:25-31, 2003
40. GRIFFIN SV, PICHLER RH, WADA T, et al: The role of cell cycle proteins in glomerular disease. Semin Nephrol 23:569-582, 2003
41. ALPERS CE, HUDKINS KL, SEGERER S, et al: Localization of SPARC in developing, mature, and chronically injured human allograft kidneys. Kidney Int 62:2073-2086, 2002
42. KIM TS, KIM JY, HONG HK, LEE HS: mRNA expression of GBM proteins and TGFß1 in human membranous nephropathy. J Pathol 189:425-430, 1999